Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-199221
Filing Date
2022-07-21
Accepted
2022-07-21 16:43:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d385969d424b5.htm 424B5 503950
2 GRAPHIC g385969g04k89.jpg GRAPHIC 40884
  Complete submission text file 0001193125-22-199221.txt   557075
Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265996 | Film No.: 221097535
SIC: 2834 Pharmaceutical Preparations